Bausch Health Companies Inc. (TSX:BHC)
Canada · Delayed Price · Currency is CAD 11.94
-0.47 (-3.79%)
Oct 30, 2026, 2:15 PM EDT
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 11,005 | 10,156 | 9,518 | 8,663 | 8,025 | 8,328 |
Other Revenue | 108 | 110 | 107 | 94 | 99 | 106 |
| 11,113 | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 | |
Revenue Growth | 10.81% | 6.66% | 9.91% | 7.79% | -3.68% | 5.07% |
Cost of Revenue | 3,043 | 3,013 | 2,782 | 2,559 | 2,364 | 2,394 |
Gross Profit | 8,070 | 7,253 | 6,843 | 6,198 | 5,760 | 6,040 |
Selling, General & Admin | 3,480 | 3,431 | 3,276 | 2,895 | 2,531 | 2,492 |
Research & Development | 638 | 629 | 616 | 604 | 529 | 465 |
Amortization of Goodwill & Intangibles | 929 | 1,001 | 1,077 | 1,077 | 1,215 | 1,375 |
Other Operating Expenses | 2 | - | - | 1 | 1 | - |
Operating Expenses | 5,049 | 5,061 | 4,969 | 4,577 | 4,276 | 4,332 |
Operating Income | 3,021 | 2,192 | 1,874 | 1,621 | 1,484 | 1,708 |
Interest Expense | -1,593 | -1,604 | -1,388 | -1,328 | -1,464 | -1,426 |
Interest & Investment Income | 43 | 48 | 33 | 26 | 14 | 7 |
Currency Exchange Gain (Loss) | -30 | -52 | -47 | -52 | -8 | 7 |
EBT Excluding Unusual Items | 1,441 | 584 | 472 | 267 | 26 | 296 |
Merger & Restructuring Charges | -68 | -86 | -36 | -95 | -68 | -73 |
Impairment of Goodwill | -1,571 | -145 | - | -493 | -824 | -469 |
Gain (Loss) on Sale of Assets | 6 | 6 | 10 | 3 | 5 | 2 |
Asset Writedown | -20 | -8 | -29 | -45 | -10 | -211 |
Legal Settlements | -47 | -61 | -220 | - | -9 | -356 |
Other Unusual Items | -74 | 191 | -12 | -80 | 752 | -205 |
Pretax Income | -353 | 367 | 167 | -390 | -129 | -1,024 |
Income Tax Expense | 475 | 247 | 239 | 221 | 83 | -87 |
Earnings From Continuing Operations | -828 | 120 | -72 | -611 | -212 | -937 |
Minority Interest in Earnings | -13 | 37 | 26 | 19 | -13 | -11 |
Net Income | -841 | 157 | -46 | -592 | -225 | -948 |
Net Income to Common | -841 | 157 | -46 | -592 | -225 | -948 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 374 | 371 | 368 | 365 | 362 | 359 |
Shares Outstanding (Diluted) | 374 | 375 | 368 | 365 | 362 | 359 |
Shares Change | 0.27% | 1.90% | 0.85% | 0.80% | 0.86% | 1.10% |
EPS (Basic) | -2.25 | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 |
EPS (Diluted) | -2.25 | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,865 | 1,003 | 1,260 | 817 | -946 | 1,157 |
Free Cash Flow Per Share | 4.99 | 2.67 | 3.42 | 2.24 | -2.61 | 3.22 |
Gross Margin | 72.62% | 70.65% | 71.10% | 70.78% | 70.90% | 71.61% |
Operating Margin | 27.18% | 21.35% | 19.47% | 18.51% | 18.27% | 20.25% |
Profit Margin | -7.57% | 1.53% | -0.48% | -6.76% | -2.77% | -11.24% |
Free Cash Flow Margin | 16.78% | 9.77% | 13.09% | 9.33% | -11.64% | 13.72% |
EBITDA | 4,171 | 3,400 | 3,141 | 2,885 | 2,878 | 3,260 |
EBITDA Margin | 37.53% | 33.12% | 32.63% | 32.95% | 35.43% | 38.65% |
D&A For EBITDA | 1,150 | 1,208 | 1,267 | 1,264 | 1,394 | 1,552 |
EBIT | 3,021 | 2,192 | 1,874 | 1,621 | 1,484 | 1,708 |
EBIT Margin | 27.18% | 21.35% | 19.47% | 18.51% | 18.27% | 20.25% |
Effective Tax Rate | - | 67.30% | 143.11% | - | - | - |
Revenue as Reported | 11,113 | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 |